TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this cluster in csv format
Share this page

Variant cluster associations

Hospitalization Episode Statistics (HES)

Cluster X0298
log Bayes Factor = 220.671
contains 1 variant:
rs12203592
lBF =220.671
Chr 6 : 396,321
What are variant clusters?
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C44.1 Skin of eyelid, including canthus
1.000 0.000 0.000
C44.2 Skin of ear and external auricular canal
1.000 0.000 0.000
C44.3 Skin of other and unspecified parts of face
1.000 0.000 0.000
C44.4 Skin of scalp and neck
1.000 0.000 0.000
C44.5 Skin of trunk
1.000 0.000 0.000
C44.6 Skin of upper limb, including shoulder
1.000 0.000 0.000
C44.7 Skin of lower limb, including hip
1.000 0.000 0.000
D22.1 Melanocytic naevi of eyelid, including canthus
0.000 0.000 1.000
D22.3 Melanocytic naevi of other and unspecified parts of face
0.000 0.000 1.000
D22.4 Melanocytic naevi of scalp and neck
0.000 0.000 1.000
D22.5 Melanocytic naevi of trunk
0.000 0.000 1.000
L57.0 Actinic keratosis
1.000 0.000 0.000
Z85.8 Personal history of malignant neoplasms of other organs and systems
1.000 0.000 0.000
C44 Other malignant neoplasms of skin
1.000 0.000 0.000
D04 Carcinoma in situ of skin
1.000 0.000 0.000
D22 Melanocytic naevi
0.000 0.000 1.000
C43-C44 Melanoma and other malignant neoplasms of skin
1.000 0.000 0.000
D00-D09 In situ neoplasms
1.000 0.000 0.000
Chapter II Neoplasms
1.000 0.000 0.000
L57 Skin changes due to chronic exposure to nonionising radiation
1.000 0.000 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
1.000 0.000 0.000
D03 Melanoma in situ
1.000 0.000 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
1.000 0.000 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
1.000 0.000 0.000
L80-L99 Other disorders of the skin and subcutaneous tissue
1.000 0.000 0.000
L81 Other disorders of pigmentation
0.999 0.001 0.000
L81.4 Other melanin hyperpigmentation
0.999 0.001 0.000
C43 Malignant melanoma of skin
0.999 0.001 0.000
C91 Lymphoid leukaemia
0.998 0.002 0.000
D03.3 Melanoma in situ of other and unspecified parts of face
0.998 0.002 0.000
C91.1 Chronic lymphocytic leukaemia
0.998 0.002 0.000
D22.0 Melanocytic naevi of lip
0.000 0.002 0.998
D04.3 Skin of other and unspecified parts of face
0.997 0.003 0.000
L00-L08 Infections of the skin and subcutaneous tissue
0.993 0.007 0.000
D22.7 Melanocytic naevi of lower limb, including hip
0.000 0.009 0.991
L08 Other local infections of skin and subcutaneous tissue
0.990 0.010 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.989 0.011 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.988 0.012 0.000
L08.9 Local infection of skin and subcutaneous tissue, unspecified
0.988 0.012 0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified
0.987 0.013 0.000
L98.9 Disorder of skin and subcutaneous tissue, unspecified
0.985 0.015 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.983 0.017 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.981 0.019 0.000
D04.7 Skin of lower limb, including hip
0.978 0.022 0.000
C69 Malignant neoplasm of eye and adnexa
0.975 0.025 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.966 0.034 0.000
D22.6 Melanocytic naevi of upper limb, including shoulder
0.000 0.037 0.963
D04.4 Skin of scalp and neck
0.962 0.038 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.961 0.039 0.000
C43.7 Malignant melanoma of lower limb, including hip
0.960 0.040 0.000
C69.3 Choroid
0.958 0.042 0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.958 0.042 0.000
C44.0 Skin of lip
0.956 0.044 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.953 0.047 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.952 0.048 0.000
L85 Other epidermal thickening
0.951 0.049 0.000
C90.0 Multiple myeloma
0.941 0.059 0.000
D04.6 Skin of upper limb, including shoulder
0.939 0.061 0.000
L85.8 Other specified epidermal thickening
0.931 0.069 0.000
D22.2 Melanocytic naevi of ear and external auricular canal
0.000 0.086 0.914
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.914 0.086 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.903 0.097 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.896 0.104 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.894 0.106 0.000
D48.5 Skin
0.893 0.107 0.000
C44.9 Malignant neoplasm of skin, unspecified
0.892 0.108 0.000
D04.5 Skin of trunk
0.885 0.115 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.884 0.116 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.874 0.126 0.000
C43.4 Malignant melanoma of scalp and neck
0.869 0.131 0.000
D22.9 Melanocytic naevi, unspecified
0.000 0.131 0.869
D47.2 Monoclonal gammopathy
0.869 0.131 0.000
C85.1 B-cell lymphoma, unspecified
0.864 0.136 0.000
L04 Acute lymphadenitis
0.861 0.139 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.852 0.148 0.000
C69.9 Eye, unspecified
0.844 0.156 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.843 0.157 0.000
C83.0 Small cell (diffuse)
0.842 0.158 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.842 0.158 0.000
L56 Other acute skin changes due to ultraviolet radiation
0.842 0.158 0.000
L83 Acanthosis nigricans
0.841 0.159 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.841 0.159 0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.838 0.162 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.832 0.168 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.831 0.169 0.000
D04.1 Skin of eyelid, including canthus
0.818 0.182 0.000
D03.8 Melanoma in situ of other sites
0.811 0.189 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.803 0.197 0.000
D03.4 Melanoma in situ of scalp and neck
0.798 0.202 0.000
C83.3 Large cell (diffuse)
0.797 0.203 0.000
C81 Hodgkin's disease
0.796 0.204 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.783 0.216 0.000
L95 Vasculitis limited to skin, not elsewhere classified
0.783 0.217 0.000
Z85 Personal history of malignant neoplasm
0.782 0.218 0.000
C69.4 Ciliary body
0.780 0.220 0.000
L81.9 Disorder of pigmentation, unspecified
0.779 0.221 0.000
D38.1 Trachea, bronchus and lung
0.778 0.222 0.000
L98.4 Chronic ulcer of skin, not elsewhere classified
0.778 0.222 0.000
L93 Lupus erythematosus
0.776 0.224 0.000
C34 Malignant neoplasm of bronchus and lung
0.775 0.225 0.000
D04.2 Skin of ear and external auricular canal
0.773 0.227 0.000
D48.1 Connective and other soft tissue
0.772 0.228 0.000
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs
0.772 0.228 0.000
L80 Vitiligo
0.769 0.231 0.000
D04.9 Skin, unspecified
0.769 0.231 0.000
D48.4 Peritoneum
0.768 0.232 0.000
L03 Cellulitis
0.758 0.242 0.000
Z85.6 Personal history of leukaemia
0.757 0.243 0.000
D43.2 Brain, unspecified
0.757 0.243 0.000
C95 Leukaemia of unspecified cell type
0.755 0.245 0.000
D09 Carcinoma in situ of other and unspecified sites
0.754 0.246 0.000
L60-L75 Disorders of skin appendages
0.752 0.248 0.000
C69.6 Orbit
0.751 0.249 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.748 0.252 0.000
L03.8 Cellulitis of other sites
0.743 0.257 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.742 0.257 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.742 0.258 0.000
C93 Monocytic leukaemia
0.740 0.260 0.000
D47.4 Osteomyelofibrosis
0.729 0.271 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.726 0.274 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.722 0.277 0.000
C37 Malignant neoplasm of thymus
0.718 0.282 0.000
C44.8 Overlapping lesion of skin
0.717 0.283 0.000
D04.0 Skin of lip
0.717 0.283 0.000
D04.8 Skin of other sites
0.717 0.283 0.000
L57.1 Actinic reticuloid
0.717 0.283 0.000
L57.2 Cutis rhomboidalis nuchae
0.717 0.283 0.000
L57.3 Poikiloderma of Civatte
0.717 0.283 0.000
L57.5 Actinic granuloma
0.717 0.283 0.000
C86 Other specified types of T/NK-cell lymphoma
0.717 0.283 0.000
C94 Other leukaemias of specified cell type
0.717 0.283 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.717 0.283 0.000
D03.0 Melanoma in situ of lip
0.717 0.283 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.717 0.283 0.000
D03.9 Melanoma in situ, unspecified
0.717 0.283 0.000
L55 Sunburn
0.717 0.283 0.000
L58 Radiodermatitis
0.717 0.283 0.000
L86 Keratoderma in diseases classified elsewhere
0.717 0.283 0.000
L87 Transepidermal elimination disorders
0.717 0.283 0.000
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
0.717 0.283 0.000
L81.0 Postinflammatory hyperpigmentation
0.717 0.283 0.000
L81.1 Chloasma
0.717 0.283 0.000
L81.3 Cafe au lait spots
0.717 0.283 0.000
L81.5 Leukoderma, not elsewhere classified
0.717 0.283 0.000
L81.6 Other disorders of diminished melanin formation
0.717 0.283 0.000
L81.7 Pigmented purpuric dermatosis
0.717 0.283 0.000
C43.0 Malignant melanoma of lip
0.716 0.283 0.000
C43.8 Overlapping malignant melanoma of skin
0.716 0.283 0.000
C91.2 Subacute lymphocytic leukaemia
0.715 0.285 0.000
C91.3 Prolymphocytic leukaemia
0.715 0.285 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.715 0.285 0.000
C91.7 Other lymphoid leukaemia
0.715 0.285 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.715 0.285 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.713 0.287 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.713 0.287 0.000
C34.1 Upper lobe, bronchus or lung
0.713 0.287 0.000
L00 Staphylococcal scalded skin syndrome
0.712 0.288 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.710 0.290 0.000
L08.0 Pyoderma
0.710 0.290 0.000
L08.1 Erythrasma
0.710 0.290 0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.708 0.292 0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]
0.708 0.292 0.000
L98.3 Eosinophilic cellulitis [Wells]
0.708 0.292 0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue
0.708 0.292 0.000
L98.7 Excessive and redundant skin and subcutaneous tissue
0.708 0.292 0.000
L98.0 Pyogenic granuloma
0.705 0.295 0.000
C70 Malignant neoplasm of meninges
0.704 0.295 0.000
C85.0 Lymphosarcoma
0.703 0.297 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.703 0.297 0.000
C90.2 Plasmacytoma, extramedullary
0.702 0.298 0.000
C69.1 Cornea
0.699 0.301 0.000
C69.2 Retina
0.699 0.301 0.000
C69.5 Lachrymal gland and duct
0.699 0.301 0.000
C69.8 Overlapping lesion of eye and adnexa
0.699 0.301 0.000
L81.2 Freckles
0.699 0.301 0.000
L04.9 Acute lymphadenitis, unspecified
0.697 0.303 0.000
C90.3 Solitary plasmacytoma
0.695 0.305 0.000
L04.0 Acute lymphadenitis of face, head and neck
0.694 0.305 0.000
L98.1 Factitial dermatitis
0.691 0.309 0.000
L01 Impetigo
0.691 0.309 0.000
C83.2 Mixed small and large cell (diffuse)
0.689 0.311 0.000
C83.4 Immunoblastic (diffuse)
0.689 0.311 0.000
C83.5 Lymphoblastic (diffuse)
0.689 0.311 0.000
C83.6 Undifferentiated (diffuse)
0.689 0.311 0.000
E03.9 Hypothyroidism, unspecified
0.687 0.313 0.000
C83.7 Burkitt's tumour
0.686 0.314 0.000
C90.1 Plasma cell leukaemia
0.686 0.314 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.684 0.316 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.683 0.317 0.000
L85.0 Acquired ichthyosis
0.682 0.318 0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris
0.682 0.318 0.000
L85.2 Keratosis punctata (palmaris et plantaris)
0.682 0.318 0.000
L85.3 Xerosis cutis
0.682 0.318 0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation
0.681 0.319 0.000
C43.9 Malignant melanoma of skin, unspecified
0.681 0.319 0.000
L88 Pyoderma gangrenosum
0.676 0.323 0.000
C91.5 Adult T-cell leukaemia
0.673 0.327 0.000
L10-L14 Bullous disorders
0.673 0.327 0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.673 0.327 0.000
L71 Rosacea
0.672 0.328 0.000
J33.0 Polyp of nasal cavity
0.672 0.328 0.000
C83.1 Small cleaved cell (diffuse)
0.672 0.328 0.000
L20-L30 Dermatitis and eczema
0.669 0.331 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.667 0.333 0.000
J33.9 Nasal polyp, unspecified
0.667 0.333 0.000
L82 Seborrhoeic keratosis
0.666 0.334 0.000
J33 Nasal polyp
0.665 0.335 0.000
C31 Malignant neoplasm of accessory sinuses
0.664 0.336 0.000
D47.1 Chronic myeloproliferative disease
0.663 0.337 0.000
L04.1 Acute lymphadenitis of trunk
0.663 0.337 0.000
C91.9 Lymphoid leukaemia, unspecified
0.661 0.339 0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.661 0.339 0.000
L08.8 Other specified local infections of skin and subcutaneous tissue
0.659 0.341 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.658 0.342 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.656 0.344 0.000
D48.3 Retroperitoneum
0.655 0.345 0.000
C33 Malignant neoplasm of trachea
0.654 0.346 0.000
C69.0 Conjunctiva
0.654 0.346 0.000
L84 Corns and callosities
0.652 0.348 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.651 0.348 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.648 0.352 0.000
C88 Malignant immunoproliferative diseases
0.647 0.353 0.000
C81.7 Other Hodgkin's disease
0.647 0.353 0.000
D43.4 Spinal cord
0.644 0.356 0.000
C34.0 Main bronchus
0.642 0.358 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.641 0.359 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.641 0.359 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.641 0.359 0.000
C91.4 Hairy-cell leukaemia
0.639 0.360 0.000
L94 Other localised connective tissue disorders
0.638 0.362 0.000
C81.9 Hodgkin's disease, unspecified
0.637 0.363 0.000
L57.4 Cutis laxa senilis
0.633 0.366 0.000
C64-C68 Malignant neoplasms of urinary tract
0.633 0.367 0.000
D00.0 Lip, oral cavity and pharynx
0.633 0.367 0.000
L73 Other follicular disorders
0.625 0.375 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.622 0.378 0.000
C34.8 Overlapping lesion of bronchus and lung
0.621 0.379 0.000
L95.8 Other vasculitis limited to skin
0.621 0.379 0.000
L03.3 Cellulitis of trunk
0.619 0.381 0.000
L04.3 Acute lymphadenitis of lower limb
0.617 0.383 0.000
L04.8 Acute lymphadenitis of other sites
0.617 0.383 0.000
D00.1 Oesophagus
0.614 0.386 0.000
C41.9 Bone and articular cartilage, unspecified
0.611 0.388 0.000
C32 Malignant neoplasm of larynx
0.611 0.389 0.000
L98.5 Mucinosis of skin
0.609 0.391 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.608 0.392 0.000
L04.2 Acute lymphadenitis of upper limb
0.607 0.393 0.000
D38.2 Pleura
0.604 0.396 0.000
D38.3 Mediastinum
0.604 0.396 0.000
D38.4 Thymus
0.604 0.396 0.000
D38.5 Other respiratory organs
0.604 0.396 0.000
D38.6 Respiratory organ, unspecified
0.604 0.396 0.000
D43.1 Brain, infratentorial
0.603 0.397 0.000
D43.3 Cranial nerves
0.603 0.397 0.000
D43.7 Other parts of central nervous system
0.603 0.397 0.000
D43.9 Central nervous system, unspecified
0.603 0.397 0.000
L56.0 Drug phototoxic response
0.603 0.397 0.000
L56.1 Drug photoallergic response
0.603 0.397 0.000
L56.2 Photocontact dermatitis [berloque dermatitis]
0.603 0.397 0.000
L56.3 Solar urticaria
0.603 0.397 0.000
L56.4 Polymorphous light eruption
0.603 0.397 0.000
L50-L54 Urticaria and erythema
0.602 0.398 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.597 0.402 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.596 0.404 0.000
L71.9 Rosacea, unspecified
0.595 0.405 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.590 0.409 0.000
L93.1 Subacute cutaneous lupus erythematosus
0.589 0.411 0.000
L27 Dermatitis due to substances taken internally
0.588 0.412 0.000
D09.1 Other and unspecified urinary organs
0.588 0.412 0.000
L93.2 Other local lupus erythematosus
0.587 0.412 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.581 0.419 0.000
C95.9 Leukaemia, unspecified
0.579 0.421 0.000
D01.3 Anus and anal canal
0.578 0.422 0.000
Z85.5 Personal history of malignant neoplasm of urinary tract
0.578 0.422 0.000
C30.0 Nasal cavity
0.576 0.424 0.000
D00.2 Stomach
0.576 0.424 0.000
C81.0 Lymphocytic predominance
0.574 0.426 0.000
D43.0 Brain, supratentorial
0.572 0.428 0.000
C41.1 Mandible
0.571 0.429 0.000
C81.3 Lymphocytic depletion
0.570 0.429 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.570 0.429 0.000
L95.9 Vasculitis limited to skin, unspecified
0.570 0.430 0.000
L66 Cicatricial alopecia [scarring hair loss]
0.565 0.435 0.000
C34.3 Lower lobe, bronchus or lung
0.564 0.436 0.000
D06 Carcinoma in situ of cervix uteri
0.563 0.437 0.000
L95.0 Livedoid vasculitis
0.561 0.439 0.000
L95.1 Erythema elevatum diutinum
0.561 0.439 0.000
Z85.0 Personal history of malignant neoplasm of digestive organs
0.560 0.439 0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
0.559 0.441 0.000
E03 Other hypothyroidism
0.559 0.441 0.000
L91 Hypertrophic disorders of skin
0.558 0.442 0.000
D02.0 Larynx
0.558 0.442 0.000
D44.1 Adrenal gland
0.558 0.442 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.557 0.443 0.000
D44.6 Carotid body
0.555 0.445 0.000
L93.0 Discoid lupus erythematosus
0.555 0.445 0.000
C81.2 Mixed cellularity
0.554 0.446 0.000
C93.1 Chronic monocytic leukaemia
0.553 0.447 0.000
D38.0 Larynx
0.552 0.448 0.000
D44.0 Thyroid gland
0.551 0.449 0.000
L81.8 Other specified disorders of pigmentation
0.550 0.450 0.000
L90 Atrophic disorders of skin
0.549 0.451 0.000
D48.6 Breast
0.547 0.453 0.000
D44.3 Pituitary gland
0.547 0.453 0.000
Z50.5 Speech therapy
0.546 0.454 0.000
Z50 Care involving use of rehabilitation procedures
0.546 0.454 0.000
D05 Carcinoma in situ of breast
0.544 0.456 0.000
C95.0 Acute leukaemia of unspecified cell type
0.541 0.459 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.541 0.459 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.541 0.459 0.000
C95.7 Other leukaemia of unspecified cell type
0.541 0.459 0.000
D09.2 Eye
0.540 0.460 0.000
D09.3 Thyroid and other endocrine glands
0.540 0.460 0.000
D09.7 Carcinoma in situ of other specified sites
0.540 0.460 0.000
D09.9 Carcinoma in situ, unspecified
0.540 0.460 0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified
0.540 0.460 0.000
L62 Nail disorders in diseases classified elsewhere
0.539 0.461 0.000
L63 Alopecia areata
0.539 0.461 0.000
L64 Androgenic alopecia
0.539 0.461 0.000
L67 Hair colour and hair shaft abnormalities
0.539 0.461 0.000
L68 Hypertrichosis
0.539 0.461 0.000
L74 Eccrine sweat disorders
0.539 0.461 0.000
L75 Apocrine sweat disorders
0.539 0.461 0.000
D01.2 Rectum
0.537 0.462 0.000
C72.0 Spinal cord
0.536 0.464 0.000
D02.1 Trachea
0.532 0.468 0.000
D02.2 Bronchus and lung
0.532 0.468 0.000
D02.3 Other parts of respiratory system
0.532 0.468 0.000
D02.4 Respiratory system, unspecified
0.532 0.468 0.000
D01.1 Rectosigmoid junction
0.532 0.468 0.000
D01.4 Other and unspecified parts of intestine
0.532 0.468 0.000
D01.5 Liver, gallbladder and bile ducts
0.532 0.468 0.000
D01.7 Other specified digestive organs
0.532 0.468 0.000
D01.9 Digestive organ, unspecified
0.532 0.468 0.000
Z50.1 Other physical therapy
0.531 0.469 0.000
C93.0 Acute monocytic leukaemia
0.530 0.469 0.000
C93.2 Subacute monocytic leukaemia
0.530 0.469 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.530 0.469 0.000
C93.7 Other monocytic leukaemia
0.530 0.469 0.000
C93.9 Monocytic leukaemia, unspecified
0.530 0.469 0.000
C66 Malignant neoplasm of ureter
0.529 0.471 0.000
C92 Myeloid leukaemia
0.528 0.472 0.000
D44.7 Aortic body and other paraganglia
0.528 0.472 0.000
D09.0 Bladder
0.527 0.473 0.000
L73.2 Hidradenitis suppurativa
0.526 0.474 0.000
L71.8 Other rosacea
0.524 0.476 0.000
D44.2 Parathyroid gland
0.521 0.479 0.000
D44.5 Pineal gland
0.521 0.479 0.000
D44.9 Endocrine gland, unspecified
0.521 0.479 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.519 0.480 0.000
C72.1 Cauda equina
0.518 0.482 0.000
C72.2 Olfactory nerve
0.518 0.482 0.000
C72.3 Optic nerve
0.518 0.482 0.000
C72.4 Acoustic nerve
0.518 0.482 0.000
C72.5 Other and unspecified cranial nerves
0.518 0.482 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.518 0.482 0.000
C72.9 Central nervous system, unspecified
0.518 0.482 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.514 0.486 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.514 0.486 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.514 0.486 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.514 0.486 0.000
C86.4 Blastic NK-cell lymphoma
0.514 0.486 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.514 0.486 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.514 0.486 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.514 0.486 0.000
C94.1 Chronic erythraemia
0.514 0.486 0.000
C94.2 Acute megakaryoblastic leukaemia
0.514 0.486 0.000
C94.3 Mast cell leukaemia
0.514 0.486 0.000
C94.4 Acute panmyelosis
0.514 0.486 0.000
C94.5 Acute myelofibrosis
0.514 0.486 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.514 0.486 0.000
C94.7 Other specified leukaemias
0.514 0.486 0.000
C96.0 Letterer-Siwe disease
0.514 0.486 0.000
C96.1 Malignant histiocytosis
0.514 0.486 0.000
C96.2 Malignant mast cell tumour
0.514 0.486 0.000
C96.3 True histiocytic lymphoma
0.514 0.486 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.514 0.486 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.514 0.486 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.514 0.486 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.514 0.486 0.000
C96.8 Histiocytic sarcoma
0.514 0.486 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.514 0.486 0.000
C38.3 Mediastinum, part unspecified
0.514 0.486 0.000
L55.0 Sunburn of first degree
0.514 0.486 0.000
L55.1 Sunburn of second degree
0.514 0.486 0.000
L55.2 Sunburn of third degree
0.514 0.486 0.000
L55.8 Other sunburn
0.514 0.486 0.000
L55.9 Sunburn, unspecified
0.514 0.486 0.000
L58.0 Acute radiodermatitis
0.514 0.486 0.000
L58.1 Chronic radiodermatitis
0.514 0.486 0.000
L58.9 Radiodermatitis, unspecified
0.514 0.486 0.000
L87.0 Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]
0.514 0.486 0.000
L87.1 Reactive perforating collagenosis
0.514 0.486 0.000
L87.2 Elastosis perforans serpiginosa
0.514 0.486 0.000
L87.8 Other transepidermal elimination disorders
0.514 0.486 0.000
L87.9 Transepidermal elimination disorder, unspecified
0.514 0.486 0.000
L99.0 Amyloidosis of skin
0.514 0.486 0.000
L99.8 Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere
0.514 0.486 0.000
C49.0 Connective and soft tissue of head, face and neck
0.513 0.487 0.000
C30.1 Middle ear
0.511 0.489 0.000
C41.2 Vertebral column
0.509 0.490 0.000
C41.3 Ribs, sternum and clavicle
0.509 0.490 0.000
C41.4 Pelvic bones, sacrum and coccyx
0.509 0.490 0.000
C41.8 Overlapping lesion of bone and articular cartilage
0.509 0.490 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.509 0.491 0.000
L94.9 Localised connective tissue disorder, unspecified
0.508 0.491 0.000
Z50.4 Psychotherapy, not elsewhere classified
0.508 0.492 0.000
L59.0 Erythema ab igne [dermatitis ab igne]
0.508 0.492 0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified
0.508 0.492 0.000
L21 Seborrhoeic dermatitis
0.508 0.492 0.000
L27.0 Generalised skin eruption due to drugs and medicaments
0.507 0.493 0.000
C70.0 Cerebral meninges
0.505 0.495 0.000
C70.1 Spinal meninges
0.505 0.495 0.000
C70.9 Meninges, unspecified
0.505 0.495 0.000
C71 Malignant neoplasm of brain
0.505 0.495 0.000
J33.1 Polypoid sinus degeneration
0.501 0.499 0.000
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation
0.499 0.501 0.000
C81.1 Nodular sclerosis
0.499 0.501 0.000
D01.0 Colon
0.498 0.502 0.000
L01.1 Impetiginisation of other dermatoses
0.495 0.505 0.000
D48.7 Other specified sites
0.495 0.505 0.000
C65 Malignant neoplasm of renal pelvis
0.495 0.505 0.000
C31.0 Maxillary sinus
0.493 0.507 0.000
L71.1 Rhinophyma
0.493 0.507 0.000
C91.0 Acute lymphoblastic leukaemia
0.489 0.510 0.000
D42.0 Cerebral meninges
0.489 0.510 0.000
D42.1 Spinal meninges
0.489 0.510 0.000
D42.9 Meninges, unspecified
0.489 0.510 0.000
L27.1 Localised skin eruption due to drugs and medicaments
0.490 0.510 0.000
L25 Unspecified contact dermatitis
0.489 0.511 0.000
L12 Pemphigoid
0.487 0.513 0.000
L94.8 Other specified localised connective tissue disorders
0.487 0.513 0.000
L65 Other nonscarring hair loss
0.487 0.513 0.000
L13 Other bullous disorders
0.486 0.514 0.000
L85.9 Epidermal thickening, unspecified
0.486 0.514 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.485 0.515 0.000
L03.9 Cellulitis, unspecified
0.485 0.515 0.000
C49.4 Connective and soft tissue of abdomen
0.484 0.516 0.000
L14 Bullous disorders in diseases classified elsewhere
0.483 0.517 0.000
L10 Pemphigus
0.483 0.517 0.000
L71.0 Perioral dermatitis
0.482 0.518 0.000
L70 Acne
0.482 0.518 0.000
L73.8 Other specified follicular disorders
0.481 0.519 0.000
L02 Cutaneous abscess, furuncle and carbuncle
0.480 0.520 0.000
L22 Diaper [napkin] dermatitis
0.480 0.520 0.000
L26 Exfoliative dermatitis
0.480 0.520 0.000
L24 Irritant contact dermatitis
0.480 0.520 0.000
C31.1 Ethmoidal sinus
0.476 0.524 0.000
C31.2 Frontal sinus
0.476 0.524 0.000
C31.3 Sphenoidal sinus
0.476 0.524 0.000
C31.8 Overlapping lesion of accessory sinuses
0.476 0.524 0.000
C31.9 Accessory sinus, unspecified
0.476 0.524 0.000
D44.8 Pluriglandular involvement
0.476 0.524 0.000
L01.0 Impetigo [any organism] [any site]
0.474 0.526 0.000
E03.8 Other specified hypothyroidism
0.472 0.528 0.000
L50 Urticaria
0.472 0.528 0.000
C38.0 Heart
0.472 0.528 0.000
C38.1 Anterior mediastinum
0.472 0.528 0.000
C38.2 Posterior mediastinum
0.472 0.528 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.472 0.528 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.470 0.530 0.000
L20 Atopic dermatitis
0.468 0.532 0.000
C46 Kaposi's sarcoma
0.467 0.533 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.467 0.533 0.000
C39.0 Upper respiratory tract, part unspecified
0.464 0.536 0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.464 0.536 0.000
C39.9 Ill-defined sites within the respiratory system
0.464 0.536 0.000
C88.1 Alpha heavy chain disease
0.464 0.536 0.000
C88.2 Gamma heavy chain disease
0.464 0.536 0.000
C88.3 Immunoproliferative small intestinal disease
0.464 0.536 0.000
C88.7 Other malignant immunoproliferative diseases
0.464 0.536 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.464 0.536 0.000
C73 Malignant neoplasm of thyroid gland
0.464 0.536 0.000
L03.2 Cellulitis of face
0.462 0.538 0.000
L91.0 Keloid scar
0.461 0.539 0.000
L05 Pilonidal cyst
0.460 0.540 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.457 0.542 0.001
L94.1 Linear scleroderma
0.457 0.542 0.000
L94.3 Sclerodactyly
0.457 0.542 0.000
L94.4 Gottron's papules
0.457 0.542 0.000
L94.5 Poikiloderma vasculare atrophicans
0.457 0.542 0.000
L94.6 Ainhum
0.457 0.542 0.000
C32.9 Larynx, unspecified
0.457 0.543 0.000
D05.7 Other carcinoma in situ of breast
0.457 0.543 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.457 0.543 0.000
C41.0 Bones of skull and face
0.456 0.544 0.000
C00 Malignant neoplasm of lip
0.454 0.546 0.000
D44.4 Craniopharyngeal duct
0.453 0.546 0.000
L72 Follicular cysts of skin and subcutaneous tissue
0.453 0.547 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.451 0.548 0.000
C74 Malignant neoplasm of adrenal gland
0.449 0.551 0.000
C67 Malignant neoplasm of bladder
0.449 0.551 0.000
L73.0 Acne keloid
0.448 0.552 0.000
L73.1 Pseudofolliculitis barbae
0.448 0.552 0.000
J33.8 Other polyp of sinus
0.448 0.552 0.000
D39.2 Placenta
0.446 0.554 0.000
D39.7 Other female genital organs
0.446 0.554 0.000
D39.9 Female genital organ, unspecified
0.446 0.554 0.000
D39.1 Ovary
0.446 0.554 0.000
C49.1 Connective and soft tissue of upper limb, including shoulder
0.442 0.558 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.